NSE · SANOFICONR
Sanofi Consumer Healthcare India Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹897 Cr with net profit ₹240 Cr — a 26.77% net margin, versus 24.54% the period before.
Shareholding
As of 2026-06-30
- Promoter71.27%
- Public8.27%
- FII2.6%
- DII17.86%
47,511 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.39× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Pharmaceuticals - Multinational · ranked #3 of 6 by market cap · medians across 5 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Glaxosmithkline Pharmaceuticals Ltd. | ₹44,493 Cr | 160.15 | 19.62 | 45.69% | 27.11% |
| Pfizer Ltd. | ₹21,754 Cr | 108.86 | 5.18 | 17.19% | 28.61% |
| Sanofi Consumer Healthcare India Ltd.(this company) | ₹10,929 Cr | 161.19 | 31.14 | 76.46% | 28.01% |
| Sanofi India Limited | ₹7,876 Cr | 76.77 | 9.43 | 42.11% | 20.53% |
| Novartis India Ltd. | ₹3,950 Cr | 156.4 | 4.82 | 11.39% | 26.38% |
| Abbott India Limited | ₹464 Cr | 149.29 | 12.35 | 37.86% | 13.6% |
AI analysis
AI-generated · google/gemini-2.5-flashSanofi Consumer Healthcare India Ltd. is listed with a market capitalization of Rs 10395 Cr. The company reported revenue of Rs 896.8 Cr and a PE ratio of 43.36. Its EPS stands at 104.39, with a book value per share of Rs 166.96.
Positives
- +The company's Return on Capital Employed (ROCE) is high at 75.604%.
- +Return on Equity (ROE) is strong at 73.1%.
- +The debt-to-equity ratio is low at 0.07, indicating limited financial leverage.
- +Promoter holding is substantial at 71.2713% as of March 31, 2026.
- +Net profit has grown from Rs 164.9 Cr in Dec 2023 to Rs 240.1 Cr in Dec 2025.
Negatives
- −Promoter holding has decreased from 71.2713% in Sept 2025 to 71.2713% in Mar 2026.
- −FII holding has decreased from 3.2403% in Jun 2025 to 2.7603% in Mar 2026.
- −DII holding has declined from 25.4805% in Mar 2025 to 17.5672% in Mar 2026.
Financial Performance
Over the past three years, Sanofi Consumer Healthcare India Ltd. has demonstrated revenue growth, with annual revenue increasing from Rs 559.5 Cr in Dec 2023 to Rs 896.8 Cr in Dec 2025. Net profit also rose from Rs 164.9 Cr in Dec 2023 to Rs 240.1 Cr in Dec 2025. The EPS grew from 71.6 in Dec 2023 to 104.27 in Dec 2025.
Profitability & Returns
The company exhibits strong profitability metrics, with a Return on Equity (ROE) of 73.1% and a Return on Capital Employed (ROCE) of 75.604%. The EPS for the latest reported annual period (Dec 2025) is 104.27. However, profit margin information is not available in the provided data.
Balance Sheet
Sanofi Consumer Healthcare India Ltd. maintains a low debt-to-equity ratio of 0.07, indicating minimal reliance on debt financing. The book value per share is Rs 166.96. No dividend yield information is available in the provided data.
Ownership & Pledges
As of March 31, 2026, the promoter holding in Sanofi Consumer Healthcare India Ltd. stands at 71.2713%. Retail public shareholding is 8.4012%. There were no promoter pledges reported for the latest period.
Regulatory & Surveillance
No information regarding regulatory actions or inclusion in any surveillance frameworks has been provided for Sanofi Consumer Healthcare India Ltd. All reported figures and shareholding data are as of the latest available periods.
Data as of — price: 2026-07-30 · financials: Dec 25 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Sanofi Consumer Healthcare India Ltd.share price & fundamentals